Delivery Order SPE2DB24D2013-SPE2DB25FCKEY
Award Date 9/18/25
Potential Completion Date 10/9/25
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,815.63 to AmerisourceBergen Drug Corp for the supply of Bosulif 400 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of June 30, 2025. The award was issued on June 6, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Bosulif is a targeted cancer therapy medication, reflecting the...
- AmerisourceBergen Drug Corp was awarded a competitively bid delivery order valued at $23,631.26 for BOSULIF 400 mg tablets (30-count packages) by the Defense Logistics Agency Medical Supply Chain on August 20, 2025, with an ultimate completion date of September 11, 2025. The contract employs firm fixed-price pricing with no set-aside designation, and performance will be executed from the contractor's Conshohocken, Pennsylvania location. This delivery order falls under AmerisourceBergen's...
- AmerisourceBergen Drug Corp received a firm fixed price delivery order valued at $5,704.45 from the Defense Logistics Agency (DLA) for 120 tablets of Bosulif 100 mg, a targeted cancer therapy medication. Awarded on September 17, 2025, with an ultimate completion date of October 8, 2025, this non-set-aside contract represents a competitive award to support federal medical procurement needs. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Bosulif 100 mg tablets (120-count units) with a contract ceiling value of $11,408.90. This firm fixed-price delivery order, with an ultimate completion date of October 2, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,704.45 on July 2, 2025, for the supply of Bosulif 100 mg tablets (120-count units). This firm fixed-price, competitively awarded contract, which is non-set-aside, will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of July 24, 2025. The award represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government,...
- The Defense Logistics Agency awarded a $23,631.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Bosulif 400 mg tablets (30-count units) under a non-competitive, non-set-aside procurement. The order, issued on September 9, 2025, with completion targeted for September 30, 2025, represents a single delivery against AmerisourceBergen's existing pharmaceutical supply contract vehicle. The pharmaceutical products will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a $11,815.63 delivery order to AmerisourceBergen Drug Corp for the supply of Bosulif 400 mg tablets (30-count units) under a firm fixed price contract type. The delivery order was competitively awarded without a set-aside designation and carries an ultimate completion date of July 24, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply transaction. This delivery order is...
- The Defense Logistics Agency awarded a $11,815.63 delivery order to AmerisourceBergen Drug Corp for BOSULIF 400 mg tablets (30-count units) on September 2, 2025, with an ultimate completion date of September 23, 2025. This firm fixed-price contract, utilizing no set-aside designation, represents a competitive award under the company's broader pharmaceutical supply agreements with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The $10,955.43 firm fixed-price contract is for the supply of BOSULIF 400 MG TABLET 30S, a pharmaceutical product. The award has an ultimate completion date of August 29, 2024 and is not a set-aside contract. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of prescription...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Bosulif 400 mg tablets, a medication used to treat certain types of leukemia. The contract has a ceiling value of $11,334.07 and is a firm fixed-price delivery order. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...